A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for Lichen Planopilaris
47 locations incl. Birmingham
Sponsor: Priovant Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07532603·Phase 2, Phase 3·Recruiting·Listed Apr 2026
Clinical Study Center
Clinical research site in Boston, Massachusetts · 800 BOYLSTON ST FL 16, BOSTON, MA 02199-1900 · (857) 400-9211 · Website
Part of Clinical Study Center
As of July 2026, 15 paid clinical trials are recruiting at Clinical Study Center in Boston, Massachusetts. Active studies at this site cover conditions such as Transthyretin Amyloidosis With Cardiomyopathy, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2 and Acid Lipase Deficiency. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Clinical Study Center (15)
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for COVID-19 Infection
65 locations incl. Canoga Park
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07013474·Phase 3·Recruiting·Listed Jun 2025
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for Transthyretin Amyloidosis With Cardiomyopathy
39 locations incl. La Jolla
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT07052903·Phase 3·Recruiting·Listed Jul 2025
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for Non-Small Cell Lung Cancer
89 locations incl. Chandler
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for Generalized Myasthenia Gravis
32 locations incl. Birmingham
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT04202341·Recruiting·Listed Dec 2019
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
for Breast Cancer
40 locations incl. Tucson
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06016738·Phase 3·Recruiting·Listed Aug 2023
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
for Prosthetic-joint Infection
13 locations incl. Sarasota
Sponsor: Peptilogics
Sex: All·Age: 18 - 80
Code: NCT07214311·Phase 2, Phase 3·Recruiting·Listed Oct 2025
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
for Acute Hepatic Porphyria
11 locations incl. Birmingham
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 12+
Code: NCT04883905·Recruiting·Listed May 2021
Lysosomal Acid Lipase (LAL) Deficiency Registry
for Lysosomal Acid Lipase Deficiency
20 locations incl. Phoenix
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: All ages
Code: NCT01633489·Recruiting·Listed Jul 2012
A Prospective Sub-Study of the Global Hypophosphatasia Registry
for Hypophosphatasia
12 locations incl. Hartford
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: All ages
Code: NCT05234567·Recruiting·Listed Feb 2022
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
for Transthyretin Amyloidosis With Cardiomyopathy
4 locations incl. Naples
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07358078·Recruiting·Listed Jan 2026
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
for Alpha-1 Antitrypsin Deficiency (AATD)
3 locations incl. Boston
Sponsor: Tessera Therapeutics, Inc.
Sex: All·Age: 18 - 70
Code: NCT07227207·Phase 1, Phase 2·Recruiting·Listed Nov 2025
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
for Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
8 locations incl. Aurora
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT07223203·Phase 3·Recruiting·Listed Oct 2025
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
for Alpha 1-Antitrypsin Deficiency
3 locations incl. Birmingham
Sponsor: Beam Therapeutics Inc.
Sex: All·Age: 18 - 70
Code: NCT06389877·Phase 1, Phase 2·Recruiting·Listed Apr 2024
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
for Atypical Hemolytic-Uremic Syndrome
6 locations incl. Aurora
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: All ages
Code: NCT01522183·Recruiting·Listed Jan 2012
More research sites in Boston
- Massachusetts General Hospital (694 trials)
- Brigham and Women's Hospital (346 trials)
- Dana-Farber Cancer Institute (341 trials)
- Beth Israel Deaconess Medical Center (265 trials)
- Boston Children's Hospital (259 trials)
- Dana Farber Cancer Institute (221 trials)
- Tufts Medical Center (107 trials)
- Boston Medical Center (94 trials)
- Massachusetts General Hospital Cancer Center (57 trials)
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA (28 trials)
Explore more
Paid clinical trials in Boston, MA · Massachusetts clinical trials